Stroke Reports
Sunday, December 15th, 2013
STROKEAHA: December 12, 2013 Background and Purpose—When optimally managed, patients with stroke are less likely to have further vascular events. We aimed to identify factors associated with optimal use of secondary prevention therapies in long-term survivors of stroke. Methods—We carefully documented discharge medications at baseline and self-reported use of medications at annual follow-up in the Northeast Melbourne […]
Stroke Reports
Sunday, December 15th, 2013
STROKEAHA: December 12, 2013 Background and Purpose—Because robotic devices record the kinematics and kinetics of human movements with high resolution, we hypothesized that robotic measures collected longitudinally in patients after stroke would bear a significant relationship to standard clinical outcome measures and, therefore, might provide superior biomarkers. Methods—In patients with moderate-to-severe acute ischemic stroke, we used […]
Stroke Reports
Sunday, December 15th, 2013
STROKEAHA: December 12, 2013 Background and Purpose—The Interventional Management of Stroke (IMS)-III trial randomized patients with acute ischemic stroke to intravenous tissue-type plasminogen activator (tPA) plus endovascular therapy versus intravenous tPA therapy alone within 3 hours from symptom onset. A predefined secondary hypothesis was that subjects with significant early ischemic change on the baseline scan would […]
Stroke Reports
Sunday, December 15th, 2013
CIRCOUTCOMES: December 10, 2013 Background—The prevalence of severe obesity is rising in the United States. Although mild to moderately elevated body mass index (BMI) is associated with reduced mortality after acute ischemic stroke, less is known about severe obesity. Methods and Results—Patients with acute ischemic stroke (n=1791) ≥45 years were identified from the biethnic population–based Brain […]
Stroke Reports
Sunday, December 15th, 2013
J Am Heart Assoc: December 10, 2013 Background Dietary vitamin K intake is thought to decrease the risk of cardiovascular disease (CVD) by reducing vascular calcification, although vitamin K is also involved in coagulation. Studies investigating the association between phylloquinone intake and risk of stroke are scarce, and the relation with menaquinones has not been investigated to […]
Stroke Reports
Sunday, December 15th, 2013
A Statement From the American Heart Association/American Stroke Association: December 5, 2013 Background and Purpose—Stroke mortality has been declining since the early 20th century. The reasons for this are not completely understood, although the decline is welcome. As a result of recent striking and more accelerated decreases in stroke mortality, stroke has fallen from the […]
Stroke Reports
Sunday, December 15th, 2013
STROKEAHA: December 5, 2013 Background and Purpose—Whether transient global amnesia (TGA) represents an arterial insult that heralds ischemic stroke remains unclear. Therefore, we examined stroke risk after TGA in a population-based cohort. Methods—After performing chart review at our institution to validate the International Classification of Diseases, 9th Edition, Clinical Modification diagnosis code for TGA, we used […]
Stroke Reports
Sunday, December 15th, 2013
A Scientific Statement From the American Heart Association: 12/2/13 Cardiovascular diseases (CVDs) are a major source of morbidity and mortality worldwide. Despite a decline of ≈30% over the past decade, heart disease remains the leading killer of Americans.1 For rare and familial forms of CVD, we are increasingly recognizing single-gene mutations that impart relatively large effects […]
Stroke Reports
Sunday, December 15th, 2013
STROKEAHA: November 12, 2013 Is it appropriate to enroll into a clinical trial (and hence randomize to either medical or endovascular therapy) a 45-year-old patient who presents within 3 hours of onset of disabling symptoms resulting from a left M1 occlusion? This is the question many of us have faced in the course of the past […]
Stroke Reports
Sunday, December 15th, 2013
STROKEAHA: September 12, 2013 The American Heart Association in its 2013 Stroke Statistics Update1 reports the annual direct and indirect costs of stroke in the United States to be $62.7 billion, with 15% to 30% of stroke survivors being permanently disabled and 20% requiring institutional care at 3 months after stroke. Rapid recognition and accurate diagnosis are […]
